Tag Archives: National Institutes of Allergy and Infectious Diseases

Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients

Fast enrollment of the right patient populations will be critical to quickly conducting Phase III trials of COVID-19 vaccines and this will likely mean taking concerted steps to reach out to populations that can be harder to recruit for clinical trials, drug industry leaders said on a recent New York Academy of Sciences webinar. Moderna […]

Posted in Boston blog main, Boston top stories, Europe blog main, National, National blog main, New York blog main, New York top stories, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , | Comments Off on Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients

Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More

Here are the headlines from the last week in North Carolina biotech news. —Pharmaceutical services provider Quintiles (NYSE: Q) is teaming up with lab testing company Quest Diagnostics (NYSE: DGX) to provide clinical trial laboratory services around the world. Durham, NC-based Quintiles will own 60 percent of the joint venture while Quest will own the […]

Posted in National blog main, Raleigh-Durham, Raleigh-Durham blog main, Raleigh-Durham top stories | Tagged , , , , , , , , , , , , , , , , | Comments Off on Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More

Pfēnex Awarded $3.1M for Malaria Work

San Diego-based Pfēnex, a 2009 spinout from Dow Chemical, got a $3.1 million subcontract from SAIC, the Virginia-based government contractor, to help develop a scalable production process for a key Malaria antigen. Pfēnex has developed a technology platform that uses fluorescing bacteria to produce a variety of specialized protein-based products. In a statement today, the […]

Posted in National briefs, San Diego, San Diego briefs | Tagged , , , , , , , , , , , | Comments Off on Pfēnex Awarded $3.1M for Malaria Work